89Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted 227Th-conjugate therapy in mice

Broer, L. N., Knapen, D. G., Suurs, F. V., Moen, I., Giesen, D., Waaijer, S. J. H., Indrevoll, B., Ellingsen, C., Kristian, A., Cuthbertson, A. S., de Groot, D-J. A., Cole, P. E., de Vries, E. G. E., Hagemann, U. B. & Lub-de Hooge, M. N., 1-Nov-2022, In: The Journal of Nuclear Medicine. 63, 11, p. 1715-1721 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study

PanCareLIFE Consortium, CPNDS Consortium, Meijer, A. J. M., Diepstraten, F. A., Langer, T., Broer, L., Domingo, I. K., Clemens, E., Uitterlinden, A. G., de Vries, A. C. H., van Grotel, M., Vermeij, W. P., Ozinga, R. A., Binder, H., Byrne, J., van Dulmen-den Broeder, E., Garre, M. L., Grabow, D., Kaatsch, P., Kaiser, M., & 37 othersKenborg, L., Winther, J. F., Rechnitzer, C., Hasle, H., Kepak, T., Kepakova, K., Tissing, W. J. E., van der Kooi, A. L. F., Kremer, L. C. M., Kruseova, J., Pluijm, S. M. F., Kuehni, C. E., van der Pal, H. J. H., Parfitt, R., Spix, C., Tillmanns, A., Deuster, D., Matulat, P., Calaminus, G., Hoetink, A. E., Elsner, S., Gebauer, J., Haupt, R., Lackner, H., Blattmann, C., Neggers, S. J. C. M. M., Rassekh, S. R., Wright, G. E. B., Brooks, B., Nagtegaal, A. P., Drogemoller, B. I., Ross, C. J. D., Bhavsar, A. P., Zehnhoff-Dinnesen, A. A., Carleton, B. C., Zolk, O. & van den Heuvel-Eibrink, M., 14-Jul-2021, In: NPJ precision oncology. 5, 1, p. 1-8 8 p., 64.

Research output: Contribution to journal › Article › Academic › peer-review

Probody therapeutic design of 89Zr-CX-072 promotes accumulation in PD-L1 expressing tumors compared to normal murine lymphoid tissue

Giesen, D., Broer, L. N., Lub-de Hooge, M. N., Popova, I., Howng, B., Nguyen, M., Vasiljeva, O., de Vries, E. G. E. & Pool, M., 1-Aug-2020, In: Clinical Cancer Research. 26, 15, p. 3999-4009 11 p.

Research output: Contribution to journal › Article › Academic › peer-review

Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study

PanCareLIFE Consortium, Langer, T., Clemens, E., Broer, L., Maier, L., Uitterlinden, A. G., de Vries, A. C. H., van Grotel, M., Pluijm, S. F. M., Binder, H., Mayer, B., von dem Knesebeck, A., Byrne, J., van Dulmen-den Broeder, E., Crocco, M., Grabow, D., Kaatsch, P., Kaiser, M., Spix, C., Kenborg, L., & 24 othersWinther, J. F., Rechnitzer, C., Hasle, H., Kepak, T., van der Kooi, A-L. F., Kremer, L. C., Kruseova, J., Bielack, S., Sorg, B., Hecker-Nolting, S., Kuehni, C. E., Ansari, M., Kompis, M., van der Pal, H., Parfitt, R., Deuster, D., Matulat, P., Tillmanns, A., Tissing, W. J. E., Beck, J. D., Elsner, S., Zehnhoff-Dinnesen, A. A., van den Heuvel-Eibrink, M. M. & Zolk, O., Oct-2020, In: European Journal of Cancer. 138, p. 212-224 13 p.

Research output: Contribution to journal › Article › Academic › peer-review